Status:
COMPLETED
Diagnostic Strategies in Patients Suspected of Irritable Bowel Syndrome
Lead Sponsor:
Zealand University Hospital
Collaborating Sponsors:
Statens Serum Institut
University of Copenhagen
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-50 years
Brief Summary
The purpose of this study is to determine whether a clinical diagnosis of irritable bowel syndrome based on patient reported symptoms and a few blood tests is safe, and to determine whether a clinical...
Eligibility Criteria
Inclusion
- age 18-50 years
- consultant in general practice for gastrointestinal symptoms, where the GP suspects irritable bowel syndrome
- full fill the ROME III criteria
- signed informed consent
Exclusion
- alarm signals
- pregnancy
- comorbid diseases, that interfere with primary endpoint
- medicine and alcohol abuse
- patient do not speak or understand danish
- investigations for irritable bowel syndrome with in the last 3 years
- from november 2008: patients aged above 40 with a duration shorter than one year
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
149 Patients enrolled
Trial Details
Trial ID
NCT00659763
Start Date
February 1 2008
End Date
November 1 2010
Last Update
March 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Departement, Koege Hospital
Køge, Denmark, 4600